Furthermore, Muramatsu T et al. has demonstrated that YAP was frequently overexpressed in ESCC and they also showed that patients with YAP-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors. This evidence concerns the gene YAP1 and esophageal squamous cell carcinoma.